Jump to content

Draft:3-Phenylcoumarin

From Wikipedia, the free encyclopedia
3-Phenylcoumarin
Structure of 3-phenylcoumarin
Names
IUPAC name
3-phenylchromen-2-one
Other names
3-phenyl-2H-chromen-2-one
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
EC Number
  • 213-473-5
UNII
  • InChI=1S/C15H10O2/c16-15-13(11-6-2-1-3-7-11)10-12-8-4-5-9-14(12)17-15/h1-10H
    Key: HWDSXZLYIKESML-UHFFFAOYSA-N
  • C1=CC=C(C=C1)C2=CC3=CC=CC=C3OC2=O
Properties
C15H10O2
Molar mass 222.243 g·mol−1
Structure
Monoclinic[1]
Hazards
GHS labelling:
GHS07: Exclamation mark
Warning
H302
P264, P270, P301+P312+P330, P501
Safety data sheet (SDS) Sigma-Aldrich
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

3-Phenylcoumarin or 3-phenylchromen-2-one is a chemical compound that has the molecular formula C15H10O2.[2] A member of the coumarin compound family, its derivatives have been investigated for pharmacological applications, including in enzyme inhibition[3] and as anticancer agents.[4][5]

Synthesis

[edit]

3-Phenylcoumarins have been synthesized through various means, starting with different precursors and catalysts with goals of achieving better yield, different conditions of the final product for producing derivatives, ease of purification, lower toxicity or environmental impact, or other considerations.[5] One synthetic method is done via Perkin reaction in dimethyl sulfoxide from methoxy-substituted phenylacetic acid and methoxy- or ethoxy-substituted salicylaldehyde using the dehydrating agent dicyclohexylcarbodiimide.[3]

Uses

[edit]

References

[edit]
  1. ^ Matos, Maria J.; Santana, Lourdes; Uriartea, Eugenio (September 2012). "3-Phenylcoumarin". Crystallographic Communications. 68. doi:10.1107/S1600536812034277. ISSN 2056-9890.
  2. ^ "3-Phenylcoumarin". PubChem. National Library of Medicine. Retrieved June 10, 2024.
  3. ^ a b Matos, Maria João; Santana, Lourdes; Uriarte, Eugenio; Delogu, Giovanna; Corda, Marcella; Fadda, Maria Benedetta; Era, Benedetta; Fais, Antonella (June 2011). "New halogenated phenylcoumarins as tyrosinase inhibitors". Bioorganic & Medicinal Chemistry Letters. 21 (11): 3342–3345. doi:10.1016/j.bmcl.2011.04.012.
  4. ^ Rauhamäki, Sanna; Postila, Pekka A.; Niinivehmas, Sanna; Kortet, Sami; Schildt, Emmi; Pasanen, Mira; Manivannan, Elangovan; Ahinko, Mira; Koskimies, Pasi; Nyberg, Niina; Huuskonen, Pasi; Multamäki, Elina; Pasanen, Markku; Juvonen, Risto O.; Raunio, Hannu (2018-03-02). "Structure-Activity Relationship Analysis of 3-Phenylcoumarin-Based Monoamine Oxidase B Inhibitors". Frontiers in Chemistry. 6. doi:10.3389/fchem.2018.00041. ISSN 2296-2646. PMC 5840146. PMID 29552556.
  5. ^ a b Matos, Maria J.; Uriarte, Eugenio; Santana, Lourdes (2021-11-08). "3-Phenylcoumarins as a Privileged Scaffold in Medicinal Chemistry: The Landmarks of the Past Decade". Molecules. 26 (21): 6755. doi:10.3390/molecules26216755. ISSN 1420-3049. PMC 8587835. PMID 34771164.